Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study.

Xin Z, Zhihong L, Shijun L, Jinfeng Z, Huiping C, Caihong Z, Daxi J, Leishi L.

Nephrol Dial Transplant. 2009 Mar;24(3):864-9. doi: 10.1093/ndt/gfn555. Epub 2008 Oct 7.

PMID:
18840890
2.

Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome.

Dantal J, Godfrin Y, Koll R, Perretto S, Naulet J, Bouhours JF, Soulillou JP.

J Am Soc Nephrol. 1998 Sep;9(9):1709-15.

3.

Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.

Chang CF, Lin CC, Chen JY, Yang AH, Shiao MS, Kao JT, Yang WC.

Am J Kidney Dis. 2003 Sep;42(3):E18-23.

PMID:
12955707
4.

Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies.

Esnault VL, Besnier D, Testa A, Coville P, Simon P, Subra JF, Audrain MA.

J Am Soc Nephrol. 1999 Sep;10(9):2014-7.

5.

Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.

Hu W, Liu Z, Ji D, Xie H, Gong D, Li L.

J Nephrol. 2006 May-Jun;19(3):312-7.

PMID:
16874690
6.

Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.

Arai T, Yamashita S, Yamane M, Manabe N, Matsuzaki T, Kiriyama K, Kanayama Y, Himeno S, Matsuzawa Y.

Atherosclerosis. 2003 Aug;169(2):293-9.

PMID:
12921981
7.

Effects of plasma-protein A immunoadsorption on idiopathic nephrotic syndrome recurring after renal transplantation.

Dantal J, Testa A, Bigot E, Soulillou JP.

Ann Med Interne (Paris). 1992;143 Suppl 1:48-51.

PMID:
1300888
8.

Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts.

Kandus A, Ponikvar R, Buturović-Ponikvar J, Bren AF, Oblak M, Mlinšek G, Kmetec A, Arnol M.

Ther Apher Dial. 2013 Aug;17(4):438-43. doi: 10.1111/1744-9987.12093.

PMID:
23931886
9.

Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.

Saito T, Oikawa S, Sato H, Sato T, Ito S, Sasaki J.

Kidney Int Suppl. 1999 Jul;71:S37-41.

PMID:
10412734
10.

Tryptophan immunoadsorption strongly reduces proteinuria in recurrent nephrotic syndrome.

Büssemaker E, Passauer J, Franz T, Gross P.

Nephrol Dial Transplant. 2001 Jun;16(6):1270-2. No abstract available.

PMID:
11390732
11.

Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome.

Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP.

N Engl J Med. 1994 Jan 6;330(1):7-14.

12.

Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.

de Zeeuw D, Gansevoort RT, Dullaart RP, de Jong PE.

J Hypertens Suppl. 1995 Jul;13(1):S53-8.

PMID:
18800457
13.

The course of anticardiolipin antibody levels under immunoadsorption therapy.

Hauser AC, Hauser L, Pabinger-Fasching I, Quehenberger P, Derfler K, Hörl WH.

Am J Kidney Dis. 2005 Sep;46(3):446-54.

PMID:
16129206
14.

Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol.

Hamatani H, Hiromura K, Kobatake K, Yoshida H, Kobayashi S, Yoneda N, Kayakabe K, Matsumoto T, Kuroiwa T, Ueki K, Nojima Y.

Clin Exp Nephrol. 2010 Dec;14(6):619-24. doi: 10.1007/s10157-010-0333-9. Epub 2010 Sep 15.

PMID:
20842518
15.

Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.

Gupta K, Iskandar SS, Daeihagh P, Ratliff HL, Bleyer AJ.

Nephrol Dial Transplant. 2008 May;23(5):1595-9. Epub 2007 Dec 8.

PMID:
18065791
16.

Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.

Fencl F, Simková E, Vondrák K, Janda J, Chadimová M, Stejskal J, Seeman T.

Transplant Proc. 2007 Dec;39(10):3488-90.

PMID:
18089416
17.

Long-term plasmapheresis and protein A column treatment of recurrent FSGS.

Belson A, Yorgin PD, Al-Uzri AY, Salvatierra O, Higgins J, Alexander SR.

Pediatr Nephrol. 2001 Dec;16(12):985-9.

PMID:
11793085
18.

Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress/rest perfusion magnetic resonance imaging.

Bohl S, Kassner U, Eckardt R, Utz W, Mueller-Nordhorn J, Busjahn A, Thomas HP, Abdel-Aty H, Klingel R, Marcovina S, Dietz R, Steinhagen-Thiessen E, Schulz-Menger J, Vogt A.

Ther Apher Dial. 2009 Apr;13(2):129-37. doi: 10.1111/j.1744-9987.2009.00667.x.

PMID:
19379152
19.

Therapeutic apheresis in myasthenia gravis patients: a six year follow-up.

Schneidewind JM, Zettl UK, Winkler RE, Ramlow W, Tiess M, Hofmann D, Michelsen A, Weber G, Kinze EM, Adam U, Hauk L, Behnecke R, Klinkmann H.

Ther Apher. 1999 Nov;3(4):298-302.

PMID:
10608721
20.

Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature.

Saito T, Sato H, Oikawa S, Kudo K, Kurihara I, Nakayama K, Abe K, Yoshinaga K, Sakaguchi H.

Am J Nephrol. 1993;13(1):64-8. Review.

PMID:
8322843

Supplemental Content

Support Center